PUBLIC CONTRACT · 2016
41/95/2016 Hemoderivados
- Contract value
- €282,930.00
- Signed on
- 4 January 2016
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 2097204PUBLISHED SUBJECT
41/95/2016 Hemoderivados
WHO CONTRACTED
Parties involved
- Awardee
- Kedrion Portugal- Distribuição de Produtos Farmacêuticos, Lda; OCTAFHARMA- PROD. FARMACEUTICO; CSL BEHRING, LDA
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Kedrion Portugal- Distribuição de Produtos Farmacêuticos, Lda · Tax ID 508472830
- Awardee
- OCTAFHARMA- PROD. FARMACEUTICO · Tax ID 502820780
- Awardee
- CSL BEHRING, LDA · Tax ID 503047201
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €282,930.00
- Procedure base price
- €282,930.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 23 March 2016
- Award date
- 4 January 2016
- Signing date
- 4 January 2016
- Performance period
- 362 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- ACORDO QUADRO PARA FORNECIMENTO DE DERIVADOS DO PLASMA HUMANO ÀS INSTITUIÇÕES E SERVIÇOS DO SERVIÇO NACIONAL DE SAÚDE CP 2015/9
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 2038469
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.